ORCHA and Alpha MD Forge Strategic Partnership to Revolutionise Digital Health Delivery in India

Leaders in Digital Health Join Forces to Introduce Groundbreaking Products

New Delhi (India), January 15: ORCHA, the Organisation for the Review of Health and Care Apps, and Alpha MD, a leading player in healthcare innovation, are proud to announce a strategic partnership aimed at shaping and supporting digital health delivery in India. The collaboration will kick off with the launch of the ORCHA India Data Protection Mark (OIDPM), the first in a series of pioneering products set to transform the landscape of digital health in India.

Digital health is at the forefront of the healthcare revolution, providing innovative solutions that have the power to redefine patient care and outcomes. However, to fully harness the potential of these technologies, trust and compliance are paramount. The OIDPM, a brainchild of the ORCHA-Alpha MD partnership, is specifically designed to address these critical aspects.

The OIDPM is an introductory assessment that evaluates digital health products against over 100 review points, ensuring compliance with the Digital Personal Data Protection Act 2023. This rapid, independent, and objective assessment provides digital health innovators with a clear understanding of their product’s compliance status. Successful assessment will grant innovators an approved badge and a badge of excellence that opens doors to inclusion in the ORCHA Alpha MD compliance portal.

Key benefits of the ORCHA Alpha MD Partnership:

  1. Comprehensive digital health assessment: The OIDPM sets the stage for a series of groundbreaking products aimed at transforming the digital health landscape in India.
  2. Rapid, objective and independent evaluation: Digital health technologies undergo a thorough assessment within 20 days, providing innovators with timely insights into their product’s compliance with data protection regulations.
  3. Global Industry Standards Compliance: The OIDPM not only aligns with Indian regulations but draws on the Data Privacy section of the ORCHA Baseline Review which covers over 350 review points used within 70% of global industry standards, giving innovators a broader perspective on their product’s performance globally.
  4. Recognition of Excellence: Successful assessment grants innovators an approved badge, a symbol of high quality and compliance that facilitates trust among health and care professionals.
  5. Market Growth Opportunities: Inclusion in compliance portals will open doors to market growth opportunities, allowing DPDPA compliant digital health products to be seamlessly integrated into healthcare systems across India.

Quote from Liz Ashall-Payne, CEO, ORCHA:

“As leaders in digital health, ORCHA is excited to partner with Alpha MD to set a new gold standard in healthcare technology standards for India. The ORCHA India Data Protection Mark (OIDPM) signifies our commitment to robust data protection and excellence, positioning Indian healthcare apps for global recognition. This strategic partnership revolutionises digital health assessment, fostering tr’ust and confidence in India’s health ecosystem and is entirely aligned to the values underpinning ORCHA itself.” 

Quote from Jiggs Barasara, CEO, Alpha MD

“The Alpha MD and ORCHA partnership is pivotal, fortifying Indian healthcare apps for the evolving landscape of healthcare technology standards. This strategic partnership ensures robust data protection and positions these applications for global recognition, setting the gold standard for India’s health ecosystem.”

Quote from Harjinder Kang, His Majesty’s Trade Commissioner and Western India Deputy High Commissioner 

Digital Technology has transformed our lives and will continue scaling in the future, with data being the driving force.

It is great to see this partnership between UK and India implementing new standards for healthcare technology, thereby further revolutionising Indian healthcare apps in the global order.

Contact:

Fiona Costello                                                Nishi Sharma

SVP Assurance Services, ORCHA              AVP Digital Governance, Alpha MD

[email protected]                 [email protected]

About ORCHA

ORCHA is a global leader in digital health technology assurance and activation, helping healthcare professionals, commissioners, and the public to discover health apps that can make a positive impact on health outcomes. The ORCHA Assure platform is used by organisations around the world to support the identification, assurance and implementation of safe and effective digital health technologies.

About Alpha MD

Alpha MD delivers cutting-edge products that empower patients, caregivers, and stakeholders in their healthcare journey. Our diverse range of offerings also supports companies in navigating the complex healthcare and life sciences landscape, fostering advancements in India and beyond.

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Jinkushal Industries Limited Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

Standalone Revenue Grows 37.4% YoY | Consolidated Revenue Grows 15.9% YoY The Board of Directors of Jinkushal Industries Limited (“Jinkushal” or “the Company”), at its meeting held today, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, prepared in accordance with applicable provisions of the Companies Act, 2013, SEBI […]

Read More
Business G. S. Grewal Tractor and Mechanization Association

G. S. Grewal Appointed President of Tractor and Mechanization Association (TMA) for 2026–28

Tractor and Mechanization Association (TMA) has appointed Mr. G. S. Grewal as its President for the 2026–28 term. New Delhi [India], August 15: The Tractor and Mechanization Association (TMA), the apex industry body representing India’s tractor and farm mechanization sector, has appointed Mr. G. S. Grewal as its President for the 2026–28 term. The announcement was made […]

Read More
Business

Sanjivani Parenteral Limited Reports Q1 FY27 Results; EBITDA stood at Rs. 43.21 Mn with PAT at Rs. 24.91 Mn

Mumbai (Maharashtra) [India], August 14: Sanjivani Paranteral Limited (Sanjivani, The Company) (BSE: 531569), one of the emerging players in the pharmaceutical and healthcare manufacturing sector, continued to strengthen its operational performance during the year through improved efficiencies, focused execution, and a customer-centric approach across its business segments, and has announced its Unaudited Financial Results for Q1 […]

Read More